The most acclaimed theory suggests that either the impaired secretion of insulin in diabetes leads to sarcopenia due to a reduction of the growth-stimulating effect of insulin or that sarcopenic patients might be more prone to diabetes due to the loss of muscle mass that is targeted by insulin action or a combination (32). Here, INS is linked to sarcopenia.